TrialBreast cancer research and treatment2024

Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial.

Noortje Verschoor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.